aripiprazole has been researched along with topiramate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Kenna, GA; McGeary, JE; Swift, RM | 1 |
| Kenna, GA; Leggio, L; Swift, RM | 1 |
| Aubin, HJ; Daeppen, JB | 1 |
| Bruno, A; Muscatello, MR; Pandolfo, G; Romeo, VM; Scimeca, G; Zoccali, RA | 1 |
| Andrade, C | 1 |
| Goodyear, K; Haass-Koffler, CL; Kenna, GA; Leggio, L; Swift, RM; Zywiak, WH | 1 |
| Anjos-Santos, A; Barros-Santos, T; Berro, LF; Borges, ÁLN; Brandão, NRN; Brito, ACL; Cata-Preta, EG; Cruz, FC; Kisaki, ND; Libarino-Santos, M; Marinho, EAV; Oliveira, TS; Oliveira-Campos, D; Oliveira-Lima, AJ; Silva, AAF | 1 |
| Cohen, D; Veerman, SRT | 1 |
6 review(s) available for aripiprazole and topiramate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2.
Topics: Alcohol Deterrents; Alcoholism; Aripiprazole; Behavior Therapy; Disulfiram; Fructose; Humans; Naltrexone; Ondansetron; Pharmacogenetics; Piperazines; Quinolones; Topiramate | 2004 |
Emerging pharmacotherapies for alcohol dependence: a systematic review focusing on reduction in consumption.
Topics: Alcohol Abstinence; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Aripiprazole; Flupenthixol; Fluvoxamine; Fructose; Humans; Naltrexone; Piperazines; Psychotropic Drugs; Quinolones; Topiramate | 2013 |
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 3: Psychopharmacological Interventions.
Topics: Anti-Obesity Agents; Antipsychotic Agents; Aripiprazole; Cardiovascular Diseases; Fructose; Humans; Hypoglycemic Agents; Metabolic Syndrome; Metformin; Schizophrenia; Topiramate | 2016 |
[Prevention and treatment of antipsychotic induced weight gain].
Topics: Antipsychotic Agents; Aripiprazole; Humans; Metformin; Topiramate; Weight Gain | 2023 |
3 trial(s) available for aripiprazole and topiramate
| Article | Year |
|---|---|
A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol.
Topics: Adult; Alcohol Drinking; Alcoholism; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Interactions; Female; Fructose; Humans; Male; Middle Aged; Neuroprotective Agents; Piperazines; Quinolones; Topiramate; Young Adult | 2009 |
Aripiprazole plus topiramate in opioid-dependent patients with schizoaffective disorder: an 8-week, open-label, uncontrolled, preliminary study.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Diagnosis, Dual (Psychiatry); Drug Administration Schedule; Drug Therapy, Combination; Female; Fructose; Humans; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Topiramate; Treatment Outcome; Young Adult | 2014 |
Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.
Topics: Adult; Alcoholic Beverages; Alcoholism; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Drug Therapy, Combination; Female; Fructose; Humans; Male; Middle Aged; Topiramate; Treatment Outcome | 2018 |
3 other study(ies) available for aripiprazole and topiramate
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Aripiprazole and topiramate, alone or in combination, block the expression of ethanol-induced conditioned place preference in mice.
Topics: Animals; Aripiprazole; Behavior, Animal; Conditioning, Classical; Disease Models, Animal; Drug Combinations; Ethanol; Male; Mice; Topiramate | 2021 |